+Compare
CVM
Stock ticker:
ASE
AS OF
Jun 23 closing price
Price
$4.98
Change
+$0.62 (+14.22%)
Capitalization
190.64M

CVM Price Prediction, Cel-Sci Corp AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jun 23, 2022

CVM in +22.36% Uptrend, growing for three consecutive days on June 23, 2022

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CVM advanced for three days, in 250 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 17, 2022. You may want to consider a long position or call options on CVM as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CVM moved above its 50-day moving average on May 27, 2022 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CVM crossed bullishly above the 50-day moving average on June 03, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 193 cases where CVM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVM broke above its upper Bollinger Band on June 22, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.792) is normal, around the industry mean (24.800). P/E Ratio (0.000) is within average values for comparable stocks, (94.818). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.614). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (290.018).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

CVM is expected to report earnings to fall 34.78% to -15 cents per share on August 16

Cel-Sci Corp CVM Stock Earnings Reports
Q2'22
Est.
$-0.15
Q1'22
Missed
by $0.08
Q3'21
Missed
by $0.09
Q2'21
Missed
by $0.12
Q1'21
Missed
by $0.09
The last earnings report on May 16 showed earnings per share of -23 cents, missing the estimate of -15 cents. With 1.25M shares outstanding, the current market capitalization sits at 190.64M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Global Blood Therapeutics (NASDAQ:GBT), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.65B. The market cap for tickers in the group ranges from 2.5K to 244.22B. NONOF holds the highest valuation in this group at 244.22B. The lowest valued company is IMUND at 2.5K.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 10%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was -38%. AMHV experienced the highest price growth at 144%, while ATHA experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -38%. For the same stocks of the Industry, the average monthly volume growth was -54% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 71
SMR Rating: 93
Profit Risk Rating: 95
Seasonality Score: -1 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a provider of immunotherapy products for the treatment of cancer and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
8229 Boone Boulevard
Phone
+1 703 506-9460
Employees
44
Web
https://www.cel-sci.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSMRX24.40N/A
N/A
Franklin Small-Mid Cap Growth R
LMCRX27.75N/A
N/A
Lord Abbett Mid Cap Stock R3
CCWSX14.27N/A
N/A
Chautauqua International Growth Investor
ENVIX18.38N/A
N/A
VanEck Environmental Sustainability I
DSHZX8.61N/A
N/A
Brinker Capital Destinations Shelter Z

CVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with EXEL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then EXEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
+13.18%
EXEL - CVM
56%
Loosely correlated
+5.65%
KALV - CVM
49%
Loosely correlated
+7.69%
GTHX - CVM
49%
Loosely correlated
+7.29%
VCYT - CVM
46%
Loosely correlated
+16.44%
ALT - CVM
45%
Loosely correlated
+12.29%
More